These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 23060474)

  • 1. Applying the National Lung Screening Trial eligibility criteria to the US population: what percent of the population and of incident lung cancers would be covered?
    Pinsky PF; Berg CD
    J Med Screen; 2012 Sep; 19(3):154-6. PubMed ID: 23060474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving selection criteria for lung cancer screening. The potential role of emphysema.
    Sanchez-Salcedo P; Wilson DO; de-Torres JP; Weissfeld JL; Berto J; Campo A; Alcaide AB; Pueyo J; Bastarrika G; Seijo LM; Pajares MJ; Pio R; Montuenga LM; Zulueta JJ
    Am J Respir Crit Care Med; 2015 Apr; 191(8):924-31. PubMed ID: 25668622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Annual number of lung cancer deaths potentially avertable by screening in the United States.
    Ma J; Ward EM; Smith R; Jemal A
    Cancer; 2013 Apr; 119(7):1381-5. PubMed ID: 23440730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying high-risk individuals for lung cancer screening: Going beyond NLST criteria.
    Fu M; Travier N; Martín-Sánchez JC; Martínez-Sánchez JM; Vidal C; Garcia M;
    PLoS One; 2018; 13(4):e0195441. PubMed ID: 29621354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-Effectiveness Analysis of Lung Cancer Screening in the United States: A Comparative Modeling Study.
    Criss SD; Cao P; Bastani M; Ten Haaf K; Chen Y; Sheehan DF; Blom EF; Toumazis I; Jeon J; de Koning HJ; Plevritis SK; Meza R; Kong CY
    Ann Intern Med; 2019 Dec; 171(11):796-804. PubMed ID: 31683314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study.
    Ten Haaf K; Jeon J; Tammemägi MC; Han SS; Kong CY; Plevritis SK; Feuer EJ; de Koning HJ; Steyerberg EW; Meza R
    PLoS Med; 2017 Apr; 14(4):e1002277. PubMed ID: 28376113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada.
    Ten Haaf K; Tammemägi MC; Bondy SJ; van der Aalst CM; Gu S; McGregor SE; Nicholas G; de Koning HJ; Paszat LF
    PLoS Med; 2017 Feb; 14(2):e1002225. PubMed ID: 28170394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selecting High-Risk Individuals for Lung Cancer Screening: A Prospective Evaluation of Existing Risk Models and Eligibility Criteria in the German EPIC Cohort.
    Li K; Hüsing A; Sookthai D; Bergmann M; Boeing H; Becker N; Kaaks R
    Cancer Prev Res (Phila); 2015 Sep; 8(9):777-85. PubMed ID: 26076698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The performance of NLST screening criteria in Asian lung cancer patients.
    Kumar V; Becker K; Zheng HX; Huang Y; Xu Y
    BMC Cancer; 2015 Nov; 15():916. PubMed ID: 26582178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening.
    Katki HA; Kovalchik SA; Berg CD; Cheung LC; Chaturvedi AK
    JAMA; 2016 Jun; 315(21):2300-11. PubMed ID: 27179989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of risk prediction models to lung cancer screening: a review.
    Tammemägi MC
    J Thorac Imaging; 2015 Mar; 30(2):88-100. PubMed ID: 25692785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the Generalizability of the National Lung Screening Trial: Comparison of Patients with Stage 1 Disease.
    Tanner NT; Dai L; Bade BC; Gebregziabher M; Silvestri GA
    Am J Respir Crit Care Med; 2017 Sep; 196(5):602-608. PubMed ID: 28722466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline characteristics of participants in the randomized national lung screening trial.
    ; Aberle DR; Adams AM; Berg CD; Clapp JD; Clingan KL; Gareen IF; Lynch DA; Marcus PM; Pinsky PF
    J Natl Cancer Inst; 2010 Dec; 102(23):1771-9. PubMed ID: 21119104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comorbidities, smoking status, and life expectancy among individuals eligible for lung cancer screening.
    Howard DH; Richards TB; Bach PB; Kegler MC; Berg CJ
    Cancer; 2015 Dec; 121(24):4341-7. PubMed ID: 26372542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating efficacy of current lung cancer screening guidelines.
    Nemesure B; Plank A; Reagan L; Albano D; Reiter M; Bilfinger TV
    J Med Screen; 2017 Dec; 24(4):208-213. PubMed ID: 28201949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.
    Tammemagi MC; Schmidt H; Martel S; McWilliams A; Goffin JR; Johnston MR; Nicholas G; Tremblay A; Bhatia R; Liu G; Soghrati K; Yasufuku K; Hwang DM; Laberge F; Gingras M; Pasian S; Couture C; Mayo JR; Nasute Fauerbach PV; Atkar-Khattra S; Peacock SJ; Cressman S; Ionescu D; English JC; Finley RJ; Yee J; Puksa S; Stewart L; Tsai S; Haider E; Boylan C; Cutz JC; Manos D; Xu Z; Goss GD; Seely JM; Amjadi K; Sekhon HS; Burrowes P; MacEachern P; Urbanski S; Sin DD; Tan WC; Leighl NB; Shepherd FA; Evans WK; Tsao MS; Lam S;
    Lancet Oncol; 2017 Nov; 18(11):1523-1531. PubMed ID: 29055736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of the regimen of screening on lung cancer cure: a comparison of I-ELCAP and NLST.
    Yip R; Henschke CI; Yankelevitz DF; Boffetta P; Smith JP;
    Eur J Cancer Prev; 2015 May; 24(3):201-8. PubMed ID: 25089376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung cancer screening.
    Arenberg D
    Semin Respir Crit Care Med; 2013 Dec; 34(6):727-37. PubMed ID: 24258563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose CT: a useful and accessible tool for the early diagnosis of lung cancer in selected populations.
    Callol L; Roig F; Cuevas A; de Granda JI; Villegas F; Jareño J; Arias E; Albiach JM
    Lung Cancer; 2007 May; 56(2):217-21. PubMed ID: 17316889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing Lung Cancer Screening Strategies in a Nationally Representative US Population Using Transportability Methods for the National Lung Cancer Screening Trial.
    Robertson SE; Joyce NR; Steingrimsson JA; Stuart EA; Aberle DR; Gatsonis CA; Dahabreh IJ
    JAMA Netw Open; 2024 Jan; 7(1):e2346295. PubMed ID: 38289605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.